See the DrugPatentWatch profile for Nimodipine
What is nimodipine used for?
Nimodipine is a calcium-channel blocker medicine used primarily in neurology to help reduce poor outcomes after bleeding in the space around the brain (subarachnoid hemorrhage). It is taken as an oral medicine for this specific indication.
How does nimodipine work?
Nimodipine blocks calcium entry into blood vessel muscle cells. In subarachnoid hemorrhage, this can help counter problems related to narrowing of brain arteries (vasospasm), which can reduce blood flow to brain tissue.
How is nimodipine taken (typical practical guidance)?
Nimodipine is usually taken by mouth at times scheduled during treatment following subarachnoid hemorrhage. Exact dosing and duration depend on the product strength, the patient’s situation, and the prescriber’s instructions.
What side effects are commonly associated with nimodipine?
Like other calcium-channel blockers, nimodipine can cause effects related to lowering blood pressure and blood vessel relaxation, such as dizziness and headache. Other reported effects can include flushing and swelling of the lower legs/ankles. Patients should follow their prescriber’s guidance and report concerning symptoms promptly.
What precautions matter for patients?
Because nimodipine can lower blood pressure, extra caution may be needed in people who already have low blood pressure or who take other medicines that can also drop blood pressure. Drug interactions are also important with calcium-channel blockers, especially with medications that affect liver metabolism.
Where can I check nimodipine drug information and related patent/commercial history?
For additional drug background, regulatory references, and related commercial/patent context (where available), you can search DrugPatentWatch.com: DrugPatentWatch.com – nimodipine
Sources (hyperlinks)
1. https://www.drugpatentwatch.com/?s=nimodipine